|
DSG2 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.430050E-02 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
4.542300E-02 |
| Normal-vs-Stage2 |
3.266400E-01 |
| Normal-vs-Stage3 |
4.277400E-01 |
| Normal-vs-Stage4 |
6.570600E-01 |
| Stage1-vs-Stage2 |
9.567200E-01 |
| Stage1-vs-Stage3 |
7.436800E-01 |
| Stage1-vs-Stage4 |
2.833600E-01 |
| Stage2-vs-Stage3 |
8.321200E-01 |
| Stage2-vs-Stage4 |
3.267800E-01 |
| Stage3-vs-Stage4 |
4.010200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.385750E-02 |
| Normal-vs-AfricanAmerican |
2.814000E-01 |
| Normal-vs-Asian |
1.595860E-02 |
| Caucasian-vs-AfricanAmerican |
3.057600E-01 |
| Caucasian-vs-Asian |
1.302220E-01 |
| AfricanAmerican-vs-Asian |
7.335700E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.421000E-01 |
| Normal-vs-Female |
2.600600E-03 |
| Male-vs-Female |
2.101800E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
2.042800E-01 |
| Normal-vs-Extreme_Weight |
1.540840E-01 |
| Normal-vs-Obese |
2.060800E-01 |
| Normal-vs-Extreme_Obese |
4.703600E-01 |
| Normal_Weight-vs-Extreme_Weight |
7.479200E-01 |
| Normal_Weight-vs-Obese |
6.473600E-01 |
| Normal_Weight-vs-Extreme_Obese |
9.032000E-01 |
| Extreme_Weight-vs-Obese |
8.433600E-01 |
| Extreme_Weight-vs-Extreme_Obese |
9.587200E-01 |
| Obese-vs-Extreme_Obese |
8.600200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
7.426600E-01 |
| Normal-vs-Age(41-60Yrs) |
2.276600E-03 |
| Normal-vs-Age(61-80Yrs) |
2.542600E-01 |
| Normal-vs-Age(81-100Yrs) |
9.204600E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
3.275000E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
8.870400E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
8.497600E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
7.764400E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
2.606800E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
7.293400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
1.515970E-02 |
| Normal-VS-Type2 PRCC |
4.896600E-01 |
| Normal-VS-KIRP CIMP |
3.338600E-01 |
| Normal-VS-Unclassified PRCC |
5.160000E-02 |
| Type1 PRCC-VS-Type2 PRCC |
3.471600E-01 |
| Type1 PRCC-VS-KIRP CIMP |
6.184600E-01 |
| Type1 PRCC-VS-Unclassified PRCC |
5.640800E-01 |
| Type2 PRCC-VS-KIRP CIMP |
3.423600E-01 |
| Type2 PRCC-VS-Unclassified PRCC |
2.922000E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
7.769400E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
9.799800E-01 |
| Normal-vs-N1 |
9.108400E-01 |
| Normal-vs-N2 |
4.840400E-01 |
| N0-vs-N1 |
9.342600E-01 |
| N0-vs-N2 |
2.191600E-01 |
| N1-vs-N2 |
2.521400E-01 |
|
|
